Tuesday, March 17, 2009
Canadian Science Minister won't confirm belief in evolution
Canada’s science minister refuses to answer whether or not he believes in evolution on the grounds that asking questions about his religion is inappropriate.
Wednesday, February 18, 2009
Major cache of fossils unearthed in L.A.

February 18, 2009
Researchers from the George C. Page Museum at the La Brea tar pits have barely begun extracting the fossils from the sandy, tarry matrix of soil, but they expect the find to double the size of the museum's collection from the period, already the largest in the world.

Photos: Major fossil cache in L.A.

Prehistoric discovery
But researchers are perhaps even more excited about finding smaller fossils of tree trunks, turtles, snails, clams, millipedes, fish, gophers and even mats of oak leaves. In the early 1900s, the first excavators at La Brea threw out similar items in their haste to find prized animal bones, and crucial information about the period was lost.
"This gives us the opportunity to get a detailed picture of what life was like 10,000 to 40,000 years ago" in the Los Angeles Basin, said John Harris, chief curator at the Page. The find will make the museum "the major library of life in the Pleistocene ice age," he said.
The site of the old two-story parking garage, which was used by the now-defunct May Co. department store, is now owned by the Page's neighboring museum, the Los Angeles County Museum of Art. LACMA had razed the building to construct an underground parking garage that would restore parkland above the structure.
The entire Rancho La Brea area at Hancock Park is a paleontological treasure chest. Petroleum from the once-massive underground oil fields oozed to the surface over the millennia, forming bogs that trapped and killed unsuspecting animals and then preserved their skeletons. It is now a protected site, although dispensation was granted to build the new garage.
Because of the historic nature of the area, the work had to be overseen by a salvage archaeologist. In this case, the work fell to Robin Turner, founder of ArchaeoPaleo Resource Management Inc. of Culver City, which previously had overseen work on other sites at or near the tar pits. Her group hit pay dirt when the excavation got about 10 feet below the surface.
"I knew we would find fossils . . . but I never expected to find so many deposits," Turner said. "There was an absolutely remarkable quantity and quality."
There were 16 separate deposits on the site -- an amount that, by her estimate, would have taken 20 years to excavate conventionally. But with LACMA officials prodding her "to get those things out of our way" so they could build their garage, she had to find another way.
Her solution was a process similar to that used to move large living trees. Carefully identifying the edges of each deposit, her team dug trenches around and underneath them, isolating the deposits on dirt pedestals. After wrapping heavy plastic around the deposits, workers built wooden crates similar to tree boxes and lifted them out individually with a heavy crane. The biggest one weighed 123,000 pounds.
"We designed a crate so that we could take out the entire deposit without disturbing it so that, at a later date, you could do a proper excavation as you would if it were still in the ground," she said.
In 3 1/2 months, working seven days a week, she and her colleagues removed the entire collection two years ago and delivered them to the museum. For some of the deposits, she said, they had to wear oxygen tanks with full gas masks because of unusually high levels of hydrogen sulfide escaping from the soil.
The only exceptions to the crating process were the mammoth named Zed and a horse skull. Because they were separate from the other assemblages, they were partially excavated and encased in plastic casts for cleaning in the museum -- the conventional technique for recovering fossils.
Curators are excited about Zed because he appears to be about 80% complete, missing only one rear leg, a vertebra and the top of his skull, which was shaved off by excavation equipment.
Curators collected 34 mammoths in the initial excavations of the La Brea tar pits from 1906 to 1914. "But they were all disarticulated bones, jumbled together," said paleontologist Christopher A. Shaw, collections manager at the Page. Mammoths on display at the museum are assembled from the bones of many animals.
Zed's tusks also are nearly intact -- another rarity since they are made of dentin, which is much more fragile than bones.
Zed's skeleton is now being cleaned in the museum's "fish bowl" preparation room, and the team of paleontologists and volunteers has so far completed only his jawbone and some vertebrae. All researchers know so far is that he stood about 10 feet tall at the hip and was 47 to 49 years old. Mammoths normally lived to about 60, so Zed died prematurely.
Curators have found three broken ribs that were healed before his death. He probably got them from fighting with other male mammoths, "or he was just clumsy as hell," said Shelley M. Cox, who is supervising the cleaning.
The team also has begun digging through the largest crate but has so far excavated only an area about 6 feet by 4 feet and about 2 1/2 feet deep. From that small area, they have so far removed a complete saber-tooth cat skeleton, six dire-wolf skulls and bones from two other saber-tooth cats, a giant ground sloth, and a North American lion. The tar has yielded more than 700 individual plant and animal specimens, 400 of which have been cataloged, Shaw said.
The team doesn't know the ages of the deposits yet. All previous specimens from Hancock Park date from 10,000 to 40,000 years ago, and there is no reason to suspect these will be any different, but each must be radiocarbon-dated.
Individual fossil deposits in the area generally cover a time span of about 2,000 years, Harris said, and deposits that are just a few feet apart can be separated in time by thousands to tens of thousands of years. "Hopefully, the 16 [new] deposits will have 16 different ages," Shaw said.
thomas.maugh@latimes.com
Tuesday, February 17, 2009
Drug Erases Fearful Memories
Monday, February 16, 2009
A common drug can selectively target long-term memories better than other therapies.
By Emily Singer
![]() | ||||
|
A common blood-pressure drug can selectively dampen fearful memories, according to research published today in Nature Neuroscience.
The findings add support for a new approach to treating anxiety disorders: chemically blocking the emotional component of a memory as it is being recalled. In healthy volunteers, the drug was more effective than exposure therapy, one of the most common treatments for anxiety disorders, which involves repeatedly exposing patients to what they fear.
The research builds on preliminary tests in patients with post-traumatic stress disorder (PTSD), in which people who have experienced severe trauma, such as rape, are plagued by disturbing and uncontrollable memories of the event. "Anytime you can reduce the emotional component of a memory while leaving the other content intact is very exciting," says Seth Norrholm, a neuroscientist at Emory University, in Atlanta, who was not involved in the research. "We want patients to understand what triggers their fear without feeling the anxiety."
The findings also build on our understanding of memory, supporting the notion that even an old memory, once recalled, becomes labile and susceptible to alteration.
To create a memory, the brain moves information from short-term storage into long-term storage--a process called consolidation. Repeating a phone number soon after hearing it, for instance, uses short-term memory. But short-term memories are particularly vulnerable to interference; learning a second phone number shortly after the first is likely to wipe out the memory of the original number.
In recent years, scientists have discovered that the simple act of remembering a past experience requires that the memory be consolidated once again. And both animal research and some human studies have shown that during reconsolidation, long-term memories-- once thought to be fairly stable--can be more easily meddled with.
In the new experiment, researchers from the University of Amsterdam repeatedly showed healthy volunteers pictures of spiders, one image of which was followed by an electrical shock. As the person learned to link the spider with the shock, just seeing that picture triggered anxiety. Psychologist Merel Kindt and her colleagues assessed the emotional aspect of the memory by measuring how startled a volunteer was by a loud sound accompanying the picture. This "startle response" is linked to the emotional intensity of a memory and can be measured using the movement of the eye muscles as the volunteer blinks in surprise.
The next day, scientists tested the emotional association between the electric shock and the spider by measuring the volunteers' startle response after seeing the spider. During the tests, the researchers gave half of the group propranolol, a beta blocker that's been used for decades to control blood pressure, and the other half a placebo. On the third day, both groups remembered the link between the shock and the spider equally well: they both accurately reported when they expected to get a shock. But those who had been treated with the drug were less startled by sound accompanying the spider, suggesting that the emotional aspect of the memory had been dampened while the informational content was left intact.
The new findings build on decades of animal research that shows that the brain stores different types of memories in different areas. A brain region called the amygdala, often dubbed the brain's fear center, plays a central role in the storage of emotional memories. Research in animals suggests that propranolol, which blocks a certain molecule in the amygdala, interferes with reconsolidation by preventing the synthesis of proteins needed to store the memory.
Previous research has shown that propranolol can help PTSD patients. But the new study takes the work a step further, by comparing propranolol treatment with exposure therapy, commonly used with PTSD. With this treatment, patients repeatedly recall their traumatic memory in a safe environment, eventually learning to disassociate the memory from fear. "Exposure therapy is the most effective treatment for anxiety disorders," says Kindt. "But it's not successful for everyone, and patients relapse 20 to 60 percent of the time."
The researchers found that after exposure therapy (also called extinction), the fearful response to the spider could be rapidly brought back. But the same was not true for those treated with propranolol, suggesting that the memory was truly weakened or erased. "It shows that blocking reconsolidation is really different than extinction, which has been a matter of controversy," says Alain Brunet, a psychologist at McGill University, in Montreal, who has tested propranolol in PTSD patients but was not involved in the current study. Previous research suggests that exposure produces a new form of learning, rather than degrading the fearful memory. The fact that the original memory remains intact may explain the high relapse rates with this treatment, says Kindt.
Kindt's team has already tested whether the propranolol effect lasts longer than three days--a key requirement for therapeutic use--but she declined to give the results because they have been submitted for publication. Other scientists are testing additional drugs in animals to search for potentially more potent compounds. "Whether it's clinically going to be useful on its own, or perhaps in a cocktail of other agents that also dampen emotional state, only time will tell," says Todd Sacktor,a neurologist and scientist at State University of New York Downstate Medical Center, in Brooklyn.
While Kindt's study and others are promising, larger tests are required to determine how useful propranolol treatment will be, as well as the most beneficial conditions for delivery. Because the drug is widely available for other purposes, some PTSD patients have reported trying it on their own, with little success. It may be that the drug must be delivered under very controlled circumstances in order to work.